BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35211804)

  • 1. The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303.
    Miyazaki T; Saji H; Nakamura H; Nagayasu T; Okumura N; Tsuchida M; Sonobe M; Aokage K; Nakao M; Haruki T; Okada M; Suzuki K; Chida M; Yoshino I;
    Surg Today; 2022 Oct; 52(10):1463-1471. PubMed ID: 35211804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Kamohara R; Hatachi G; Doi R; Obata T; Nagayasu T
    Surg Today; 2017 Jul; 47(7):836-843. PubMed ID: 27853867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer.
    Zhang F; Ying L; Jin J; Chen K; Zhang N; Wu J; Zhang Y; Su D
    Oncotarget; 2017 Jan; 8(5):8835-8842. PubMed ID: 27823974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
    Mimae T; Saji H; Nakamura H; Okumura N; Tsuchida M; Sonobe M; Miyazaki T; Aokage K; Nakao M; Haruki T; Okada M; Suzuki K; Chida M
    Ann Surg Oncol; 2021 Nov; 28(12):7219-7227. PubMed ID: 33900499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab.
    Araki T; Tateishi K; Sonehara K; Hirota S; Komatsu M; Yamamoto M; Kanda S; Kuraishi H; Hanaoka M; Koizumi T
    Thorac Cancer; 2021 Mar; 12(5):603-612. PubMed ID: 33434414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
    Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
    Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
    Matsubara T; Takamori S; Haratake N; Fujishita T; Toyozawa R; Ito K; Shimokawa M; Yamaguchi M; Seto T; Okamoto T
    Ann Surg Oncol; 2021 Jun; 28(6):3046-3054. PubMed ID: 33084992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.
    Koh YW; Lee HW
    Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non-Small Cell Lung Cancer.
    Yotsukura M; Ohtsuka T; Kaseda K; Kamiyama I; Hayashi Y; Asamura H
    J Thorac Oncol; 2016 Aug; 11(8):1311-1318. PubMed ID: 27234603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303.
    Nakao M; Saji H; Mun M; Nakamura H; Okumura N; Tsuchida M; Sonobe M; Miyazaki T; Aokage K; Haruki T; Okada M; Suzuki K; Chida M
    Clin Lung Cancer; 2022 May; 23(3):e176-e184. PubMed ID: 34690079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretreatment Glasgow prognostic score in stage IIIB geriatric non-small cell lung cancer patients undergoing radical chemoradiotherapy.
    Topkan E; Bolukbasi Y; Ozdemir Y; Besen AA; Mertsoylu H; Selek U
    J Geriatr Oncol; 2019 Jul; 10(4):567-572. PubMed ID: 31178158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Aug; 3(8):880-6. PubMed ID: 18670306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.